Nagasu et al. analyzed real-world data on the renoprotective effects of SGLT2 inhibitors using a comprehensive longitudinal database of patients with CKD (J-CKD-DB-Ex) [22]. The gene discussed is SLC5A2; the disease is chronic kidney disease.